OptiNose, Inc.·5

Jan 8, 4:52 PM ET

Gibbs Thomas Edward 5

5 · OptiNose, Inc. · Filed Jan 8, 2019

Insider Transaction Report

Form 5
Period: 2018-12-31
Gibbs Thomas Edward
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2018-12-31$5.42/sh+611$3,3124,596 total
Footnotes (1)
  • [F1]Shares acquired under the Optinose, Inc. 2017 Employee Stock Purchase Plan on December 31, 2018 in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file
  • 5
    wf-form5_154698435653879.xmlPrimary

    FORM 5